Abstract
Post-acute sequelae of SARS-CoV-2 infection (PASC) affects a wide range of organ systems among a large proportion of patients with SARS-CoV-2 infection. Although studies have identified a broad set of patient-level risk factors for PASC, little is known about the contextual and spatial risk factors for PASC. Using electronic health data of patients with COVID-19 from two large clinical research networks in New York City and Florida, we identified contextual and spatial risk factors from nearly 200 environmental characteristics for 23 PASC symptoms and conditions of eight organ systems. We conducted a two-phase environment-wide association study. In Phase 1, we ran a mixed effects logistic regression with 5-digit ZIP Code tabulation area (ZCTA5) random intercepts for each PASC outcome and each contextual and spatial factor, adjusting for a comprehensive set of patient-level confounders. In Phase 2, we ran a mixed effects logistic regression for each PASC outcome including all significant (false positive discovery adjusted p-value < 0.05) contextual and spatial characteristics identified from Phase I and adjusting for confounders. We identified air toxicants (e.g., methyl methacrylate), criteria air pollutants (e.g., sulfur dioxide), particulate matter (PM2.5) compositions (e.g., ammonium), neighborhood deprivation, and built environment (e.g., food access) that were associated with increased risk of PASC conditions related to nervous, respiratory, blood, circulatory, endocrine, and other organ systems. Specific contextual and spatial risk factors for each PASC condition and symptom were different across New York City area and Florida. Future research is warranted to extend the analyses to other regions and examine more granular contextual and spatial characteristics to inform public health efforts to help patients recover from SARS-CoV-2 infection.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the National Institutes of Health (NIH) Agreement OTA HL161847-01 (contract number EHR-01-21) as part of the Researching COVID to Enhance Recovery (RECOVER) research program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of Weill Cornell Medicine and University of Florida gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
1Abbreviations
- PASC
- post-acute sequelae of SARS-CoV-2 infection
- COVID-19
- the 2019 novel coronavirus disease
- US
- the United States
- ZCTA5
- 5-digit ZIP Code tabulation area
- CRN
- clinical research network; PCORnet, the National Patient-Centered Clinical Research Network
- PM2.5
- fine particulate matter with diameters that are 2.5 μm and smaller
- CO
- carbon monoxide
- SO2
- sulfur dioxide
- NO2
- nitrogen dioxide
- sulfate; ammonium;-, nitrate
- OM
- organic matter
- BC
- black carbon
- DUST
- mineral dust
- SS
- sea-salt
- O3
- ozone
- ACAG
- The University of Washington at St. Louis Atmospheric Composition Analysis Group
- CACES
- The Center for Air, Climate, & Energy Solutions
- US EPA
- The United States Environmental Protection Agency
- JHU CSSE
- Johns Hopkins University, Center for Systems Science and Engineering Coronavirus Resource Center
- CDC
- The Centers for Disease Control and Prevention
- NATA
- National Air Toxics Assessment
- USDA
- US Department of Agriculture
- HUD
- Department of Housing and Urban Development
- USPS
- US Postal Service
- NACIS
- The North American Industry Classification System
- NDVI
- Normalized Difference Vegetation Index
- NDI
- Neighborhood Deprivation Index
- ED
- emergency department
- VIF
- variance inflation factor.
